The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Marguglio David J. since 2014.
This trader's CIK number is 1461753.
At the time of last reporting, Marguglio David J. was the SVP and Chief Business Officer of Adamis Pharmaceuticals Corp. (stock ticker symbol ADMP).
Also see all insider trading activities at Adamis Pharmaceuticals Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | ADMP | 0 | $0 | 11,859 | $7,115 | 0 | $0 |
| 2021 | ADMP | 0 | $0 | 50,757 | $39,844 | 22,258 | $0 |
| 2020 | ADMP | 0 | $0 | 65,300 | $40,931 | 0 | $0 |
| 2019 | ADMP | 0 | $0 | 35,706 | $55,653 | 22,258 | $0 |
| 2016 | ADMP | 0 | $0 | 22,700 | $187,717 | 0 | $0 |
| 2015 | ADMP | 0 | $0 | 29,200 | $189,498 | 0 | $0 |
| 2014 | ADMP | 0 | $0 | 29,000 | $162,568 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-18 | ADMP | Sale | 11,859 | .60 | 7,115 |
| 2021-12-01 | ADMP | Sale | 50,757 | .79 | 39,844 |
| 2021-02-21 | ADMP | Option Ex | 22,258 | .00 | 0 |
| 2020-11-18 | ADMP | Sale | 8,532 | .41 | 3,463 |
| 2020-09-29 | ADMP | Sale | 20,000 | .80 | 16,000 |
| 2020-08-18 | ADMP | Sale | 8,749 | .87 | 7,646 |
| 2020-05-18 | ADMP | Sale | 7,734 | .56 | 4,331 |
| 2020-03-18 | ADMP | Sale | 10,337 | .34 | 3,483 |
| 2020-02-24 | ADMP | Sale | 9,948 | .60 | 6,008 |
| 2019-11-18 | ADMP | Sale | 8,283 | .87 | 7,197 |
| 2019-08-19 | ADMP | Sale | 8,109 | 1.10 | 8,887 |
| 2019-05-20 | ADMP | Sale | 8,735 | 1.77 | 15,460 |
| 2019-03-20 | ADMP | Sale | 10,579 | 2.28 | 24,109 |
| 2019-02-21 | ADMP | Option Ex | 22,258 | .00 | 0 |
| 2016-06-02 | ADMP | Sale | 700 | 9.00 | 6,301 |
| 2016-05-16 | ADMP | Sale | 4,000 | 8.09 | 32,340 |
| 2016-05-09 | ADMP | Sale | 4,860 | 10.00 | 48,600 |
| 2016-05-03 | ADMP | Sale | 1,140 | 9.00 | 10,260 |
| 2016-04-14 | ADMP | Sale | 12,000 | 7.52 | 90,216 |
| 2015-04-20 | ADMP | Sale | 200 | 5.00 | 1,000 |
| 2015-04-17 | ADMP | Sale | 100 | 5.01 | 501 |
| 2015-04-16 | ADMP | Sale | 700 | 5.00 | 3,500 |
| 2015-04-13 | ADMP | Sale | 2,100 | 5.01 | 10,525 |
| 2015-04-14 | ADMP | Sale | 100 | 5.00 | 500 |
| 2015-03-04 | ADMP | Sale | 11,800 | 7.09 | 83,662 |
| 2015-03-02 | ADMP | Sale | 7,000 | 6.45 | 45,150 |
| 2015-01-08 | ADMP | Sale | 200 | 7.00 | 1,400 |
| 2015-01-05 | ADMP | Sale | 7,000 | 6.18 | 43,260 |
| 2014-12-29 | ADMP | Sale | 772 | 6.00 | 4,632 |
| 2014-12-30 | ADMP | Sale | 12,228 | 6.09 | 74,468 |
| 2014-12-12 | ADMP | Sale | 4,000 | 5.18 | 20,740 |
| 2014-09-02 | ADMP | Sale | 8,000 | 5.06 | 40,472 |
| 2014-06-02 | ADMP | Sale | 4,000 | 5.56 | 22,256 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Marguglio David J. (SVP and Chief Business Officer of Adamis Pharmaceuticals Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.